(Q72553313)
Statements
Tolerance and cerebrospinal fluid pharmacokinetics of intrathecally administered human natural interleukin-2: a phase I trial (English)
Rösener M
Schwuléra U
Menke G
Thrun A
Lissner R
Krauseneck P
Bogdahn U